Gene biomarker shows promise as alternative early Alzheimer's blood test
April 1, 2020 -- A gene called phosphoglycerate dehydrogenase (PHGDH) looks promising as a biomarker for early Alzheimer's disease based on a study of RNA blood tests published in the journal Current Biology. The results have potential to open a new avenue of research in blood testing for the disease, beyond beta amyloid and tau, researchers reported.
Discuss
April 1, 2020 -- A gene called phosphoglycerate dehydrogenase (PHGDH) looks promising as a biomarker for early Alzheimer's disease based on a study of RNA blood tests published in the journal Current Biology. The results have potential to open a new avenue of research in blood testing for the disease, beyond beta amyloid and tau, researchers reported.
Discuss GE BioPharma sale to Danaher is complete
April 1, 2020 -- The divestment of GE's BioPharma business unit to Danaher is complete, according to an announcement by both companies on March 31.
April 1, 2020 -- The divestment of GE's BioPharma business unit to Danaher is complete, according to an announcement by both companies on March 31.
Siemens wins FDA clearance for blood gas analyzer
March 31, 2020 -- Siemens Healthineers has garnered U.S. Food and Drug Administration (FDA) clearance for its RapidPoint 500e blood gas analyzer.
March 31, 2020 -- Siemens Healthineers has garnered U.S. Food and Drug Administration (FDA) clearance for its RapidPoint 500e blood gas analyzer.
Agilent launches liquid chromatography-mass spectrometry system in U.S.
March 30, 2020 -- Agilent Technologies has announced the U.S. launch of a new liquid chromatography-mass spectrometry system designed to improve diagnostic workflow in clinical laboratories.
March 30, 2020 -- Agilent Technologies has announced the U.S. launch of a new liquid chromatography-mass spectrometry system designed to improve diagnostic workflow in clinical laboratories.
Quidel receives expanded approval for COVID-19 test
March 27, 2020 -- The U.S. Food and Drug Administration has expanded Quidel's emergency use authorization for the company's Lyra SARS-CoV-2 assay, a real-time reverse transcription polymerase chain reaction test for the novel coronavirus.
March 27, 2020 -- The U.S. Food and Drug Administration has expanded Quidel's emergency use authorization for the company's Lyra SARS-CoV-2 assay, a real-time reverse transcription polymerase chain reaction test for the novel coronavirus.
Kalorama opens database of COVID-19 test instruments
March 26, 2020 -- Market research firm Kalorama Information has made available to hospitals and clinical labs a database that lists the installed base of diagnostic assay instruments that can perform tests for SARS-CoV-2 infection and COVID-19.
March 26, 2020 -- Market research firm Kalorama Information has made available to hospitals and clinical labs a database that lists the installed base of diagnostic assay instruments that can perform tests for SARS-CoV-2 infection and COVID-19.
Emerald Organic, Todos Medical team on COVID-19 tests
March 26, 2020 -- Emerald Organic Products and Todos Medical have created a joint venture to address the demand for COVID-19 screening and diagnostic testing in the U.S.
March 26, 2020 -- Emerald Organic Products and Todos Medical have created a joint venture to address the demand for COVID-19 screening and diagnostic testing in the U.S.
Fentanyl during moms' labor shows up in babies' urine
March 25, 2020 -- Fentanyl administered to pregnant women during labor may be passed on to their babies and show up in neonatal urine samples, researchers reported in the Journal of Applied Laboratory Medicine on March 24. Labs should be aware of this mode of transmission when screening for opioid abuse, they advised.
Discuss
March 25, 2020 -- Fentanyl administered to pregnant women during labor may be passed on to their babies and show up in neonatal urine samples, researchers reported in the Journal of Applied Laboratory Medicine on March 24. Labs should be aware of this mode of transmission when screening for opioid abuse, they advised.
Discuss T2 adds coronavirus test to panels, per health network deal
March 25, 2020 -- T2 Biosystems has signed a worldwide licensing agreement for a rapid test developed by New Jersey-based Hackensack Meridian Health for SARS-CoV-2.
March 25, 2020 -- T2 Biosystems has signed a worldwide licensing agreement for a rapid test developed by New Jersey-based Hackensack Meridian Health for SARS-CoV-2.
Pediatric bilirubin screening could avert transplants
March 24, 2020 -- Identifying biliary atresia in newborns using a bilirubin screening protocol could delay or prevent the need for a liver transplant by allowing them to undergo necessary surgery earlier, according to a study published March 24 in JAMA.
Discuss
March 24, 2020 -- Identifying biliary atresia in newborns using a bilirubin screening protocol could delay or prevent the need for a liver transplant by allowing them to undergo necessary surgery earlier, according to a study published March 24 in JAMA.
Discuss